These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 23290491

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. VEGF inhibitors for AMD and diabetic macular edema.
    Med Lett Drugs Ther; 2015 Mar 16; 57(1464):41-2. PubMed ID: 25758545
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Intravitreal foreign body following intravitreal anti-VEGF injection: a case report.
    Al Bdour MD, Ali ZR.
    Eye (Lond); 2014 Feb 16; 28(2):244-5. PubMed ID: 24357842
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Diffuse diabetic macular oedema treated with intravitreal bevacizumab or triamcinolone acetonide.
    Rensch F, Spandau UH, Wickenhäuser A, Jonas JB.
    Acta Ophthalmol; 2010 Mar 16; 88(2):e36-7. PubMed ID: 19210330
    [No Abstract] [Full Text] [Related]

  • 11. Bevacizumab therapy for tamoxifen-induced crystalline retinopathy and severe cystoid macular edema.
    Rahimy E, Sarraf D.
    Arch Ophthalmol; 2012 Jul 16; 130(7):931-2. PubMed ID: 22776935
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of intravitreal bevacizumab and ranibizumab treatment for diabetic macular edema.
    Ozturk BT, Kerimoglu H, Bozkurt B, Okudan S.
    J Ocul Pharmacol Ther; 2011 Aug 16; 27(4):373-7. PubMed ID: 21631366
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. OCT and cataract.
    Falavarjani KG, Modarres M, Nikeghbali A.
    Ophthalmology; 2010 Apr 16; 117(4):849; author reply 849-50. PubMed ID: 20346827
    [No Abstract] [Full Text] [Related]

  • 15. Anti-VEGF therapeutic approaches for diabetic macular edema.
    Khurana RN, Do DV, Nguyen QD.
    Int Ophthalmol Clin; 2009 Apr 16; 49(2):109-19. PubMed ID: 19349791
    [No Abstract] [Full Text] [Related]

  • 16. Two-year results of a randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus laser in diabetic macular edema.
    Soheilian M, Garfami KH, Ramezani A, Yaseri M, Peyman GA.
    Retina; 2012 Feb 16; 32(2):314-21. PubMed ID: 22234244
    [Abstract] [Full Text] [Related]

  • 17. How significant is the benefit that a patient can expect from a VEGF inhibitor?
    Johns Hopkins Med Lett Health After 50; 2012 Feb 16; 24(12):4. PubMed ID: 23757794
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Intravitreal injection of ranibizumab during cataract surgery in patients with diabetic macular edema.
    Rauen PI, Ribeiro JA, Almeida FP, Scott IU, Messias A, Jorge R.
    Retina; 2012 Oct 16; 32(9):1799-803. PubMed ID: 22495327
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.